Clinical Trial Update: Intranasal Insulin in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal insulin in Parkinson's disease has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: HealthPartners Institute | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-02-11